Unique Plan Description: eptifibatide Integrilin Protocol
Plan Selection Display: eptifibatide Integrilin Protocol
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2012-02-15 16:40:58
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2021-12-21 12:39:19
Available at all facilities: Yes

eptifibatide Integrilin Protocol
Laboratory
	CBC with Diff
		T+1;0400, spec type = Blood
	Notify MD of Lab results
		T;N, platelet count less than 100,000
IV Solutions
		Length of Therapy:  ACS w/PCI=18-24 hours or sooner if discharged; ACS w/o PCI=until discharge,  CABG up to 72 hours; PCI w/o ACS=12-24 hours or sooner if discharged.(NOTE)*
	Integrilin 0.75 mg/mL 100 mL Premix IV
		100 mL, IV
			Comment: Give 2 mcg/kg/min for patients with a creatinine clearance >/= 50 mL/min; maximum dose 15 mg/hr for patients over 121 kg. Pharmacist to calculate crcl using ACTUAL body weight.
		75 mg, EVERY BAG, 2 mcg/kg/min
		100 mL, IV
			Comment: Give 1 mcg/kg/min for patients with a creatinine clearance < 50 mL/min; maximum dose 7.5 mg/hr for patients over 121 kg. Pharmacist to calculate crcl using ACTUAL body weight.
		75 mg, EVERY BAG, 1 mcg/kg/min
Medications
	eptifibatide
		180 mcg/kg, Injection, IV Push, Once, STAT
			Comment: Maximum 22.6 mg for weight greater than 121 kg.  Administer over 1-2 minutes.
		180 mcg/kg, Injection, IV Push, Once, T;N+10
			Comment: Repeat dose 10 minutes after initial bolus if PCI. Maximum 22.6mg for weight greater than 121 kg. Administer over 1-2 minutes.

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase